DOI: 10.1128/AAC.02023-16
Article Information
PubMed
Published By
History
- Received September 18, 2016
- Returned for modification October 23, 2016
- Accepted January 30, 2017
- Published online March 24, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology.
All Rights Reserved
.
Article Versions
- Accepted Manuscript version (February 06, 2017).
- You are viewing the most recent version of this article.
Author Information
- Zackery P. Bulmana,b,
- Michael J. Satlinc,
- Liang Chend,
- Barry N. Kreiswirthd,
- Beom Soo Shine,
- Thomas J. Walshc,
- Patricia N. Holdena,b,
- Alan Forrestf,
- Roger L. Nationg,
- Jian Lig and
- Brian T. Tsujia,b
- aLaboratory for Antimicrobial Dynamics, NYS Center of Excellence in Bioinformatics & Life Sciences, Buffalo, New York, USA
- bSchool of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA
- cWeill Cornell Medical College, Cornell University, New York, New York, USA
- dPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA
- eCatholic University of Daegu, Hayang, South Korea
- fEshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA
- gDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia
- Address correspondence to Brian T. Tsuji, btsuji{at}buffalo.edu.
Citation Bulman ZP, Satlin MJ, Chen L, Kreiswirth BN, Shin BS, Walsh TJ, Holden PN, Forrest A, Nation RL, Li J, Tsuji BT. 2017. New polymyxin B dosing strategies to fortify old allies in the war against KPC-2-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 61:e02023-16. https://doi.org/10.1128/AAC.02023-16 .
